Skip to main content
    O

    Oncolytics Biotech Inc (ONCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    +0.04 (+12.53%)

    Market Cap: $44.57M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Oncolytics Biotech Inc (ONCY) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Oncolytics Biotech (ONCY) has a latest price of $0.38 on Nov 17, 2026, 70.6% below its 52-week high of $1.30. Its price fell 63.2% over the past 12 months. The month-end price fell 93.0% since May 2018, a compound annual decline of 27.1%.

    Price Chart

    From May 2018 to Oct 2026, its highest month-end close was $6.10 in May 2018 and its lowest $0.34 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ONCY with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ONCY.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 54.0%, and over 6 months it fell 50.6%. The month-end price fell 74.4% over the 3 years through Oct 2026, a compound annual decline of 36.5%.

    PeriodChange
    1 month-22.9%
    3 months-54.0%
    6 months-50.6%
    12 months-63.2%
    12 months, with dividends-63.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-74.4%-36.5%
    5 years-79.1%-26.9%
    Since May 2018-93.0%-27.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 163.0%, and its weakest was 2020, when it fell 50.0%.

    YearCloseChange
    2026 through Oct 2026$0.43-51.3%
    2025$0.87-4.4%
    2024$0.91-32.3%
    2023$1.35-17.2%
    2022$1.63+17.3%
    2021$1.39-41.6%
    2020$2.38-50.0%
    2019$4.76+163.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 31.6% below its 50-day average of $0.56 and 53.5% below its 200-day average of $0.82.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.38
    52-week high$1.30-70.6%
    52-week low$0.34+13.8%
    50-day average$0.56-31.6%
    200-day average$0.82-53.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 80.0%.

    MeasureValue
    1-year beta1.23
    Largest fall, 1 year-73.2%
    Largest fall, 3 years-80.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ONCY

    What is ONCY's 1-year price change?

    Oncolytics Biotech's price fell 63.2% over the past 12 months. With dividends included, the 12-month total return was -63.2%.

    What is ONCY's 5-year price change?

    Oncolytics Biotech's month-end price fell 79.1% over the 5 years through Oct 2026, a compound annual decline of 26.9%. These figures leave out dividends.

    What is ONCY's 52-week high and low?

    Oncolytics Biotech's 52-week high is $1.30 and its 52-week low is $0.34. Its latest price of $0.38 on Nov 17, 2026 is 70.6% below the high.

    What is ONCY's beta?

    Oncolytics Biotech's 1-year beta against the S&P 500 is 1.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 73.2%.

    Is the ONCY chart free?

    Yes. Advanced Charting for ONCY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.